Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Here come the wheedling, threatening and cajoling posts...
View:
Post by gojotv! on May 03, 2022 4:52pm

Here come the wheedling, threatening and cajoling posts...

...by Big Pharma agents, saying that TLT shareholders would be wise to sell out cheap.
Counterintuitive, isn't it?
They say that a small company can't bring THE CURE FOR CANCER to market, as if TLT was merely hawking a better mousetrap.
They say that Canada would do better dominated by foreign pharma, rather than establishing a new generation, 21st century multi-national, light-based Pharma-Tech corporation of our own.
Absurd, no?
They say that shareholders should be eager to sell for pennies now, rather than hold to the peak of the stock... to pick TLT's withering blossoms rather than enjoy its rich, nourishing fruit.
Hogwash, n'est-ce pas?
You can almost smell the desperation of the failing Big Pharma model, faced with an agile, multi-sku, all-curing paradigm in medecine. Because that is what TLT is revealing itself to be...
Can't bring this cure to market?
Pshaw!
The market will come screaming to TLT.
Their lives literally depend on it.
They will mob practitioners, breaking down the doors to get to a chance at a pain-free future. To get a chance at a future at all!
We're not selling a fad here. We don't make crocheted toilet-roll covers.
We are curing the cancers that engender pain and death for millions, and the Covid that nearly shut down the world itself.
If you're foolish enough to believe these Adderall-happy speculators, posting penny-ante estimates of TLT's future value, please sell now, and rid our shareholder base of your stupidity.
Because real shareholders are here to found a corporation that has better products than Apple and Microsoft combined.
At a fraction of the development cost.
Stop thinking like blinkered, colonized Canadians and start thinking like the kind of winners who've reaped the rewards of burgeoning tech in the past.
Because that's what this is.
Get into it.
Comment by robertshaw on May 03, 2022 4:59pm
Agree, not selling, buy when Blowjobjoe's bosses dumping under RDW 's recent buying price instead... And thank Blowjobjoe's bosses later... When we get the BTD.
Comment by Legit62 on May 03, 2022 6:27pm
Totally agree, i keep buying at these discount prices, staying long, because when the vaccine and BTD come to fruition, we are going to rock, i still believe all long term holders are hanging tight, not selling, but those cheap shares are evaporating fast, also still believe we will partner up way before then, IMO
Comment by Legit62 on May 03, 2022 6:30pm
Our technology is just too good, this is way underpriced, but not for long, science will prevail , not short sellers
Comment by LaserStock29 on May 03, 2022 10:34pm
For $2 alone.. it's BTD with NMIBC  Our small molecule in trial is TLD-1433 Not Ruthenium  for GBM and NSCLC  years away once Phase 1 starts (whenever that is) probably 2023-2024   so lol  ok Not Osmium (if it's still a thing)  the Bladder Cap is 1.1b opportunity maybe 2b        So for TLD-1433 licenced out for Bladder ...more  
Comment by robertshaw on May 04, 2022 8:22am
Accumulate before May 14th, under 0.32 (RDW 's recent buying price) is a good bargin.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250